OrbiMed
Biopharmaceutical Diagnostics Disease Management Drug Discovery Healthcare
Artificial Intelligence Computer Vision Deep Learning

Business Overview

2010
Date Founded
Venture Capital
Investor Type
$5.3M -
Cheque Size
$15,000,000,000
Total Funds Raised

From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.

We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.

Life Sciences Focus

The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease. These trends have caused a steady increase in the level of healthcare spending in the industrialized world, led by the U.S. which now spends over 17% of its GDP on healthcare. The healthcare industry’s powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities.

Investment Preference

Series
Series A, Series B, Series C, Series D
Business Model
B2B, B2C
Offering Type
Hardware, Software
AI Type
Artificial Intelligence Computer Vision Deep Learning Machine Learning Natural Language Processing Robotics
Sectors
Biopharmaceutical Diagnostics Disease Management Drug Discovery Healthcare HomeCare Life Sciences Lifestyle Management Medical Imaging Prevention Synthetic Data

Team

OrbiMed
Anat Naschitz
Managing Director
OrbiMed
Nissim Darvish
Sr. Managing Director
View Email

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

BiomX
Merged
Software
B2B
$56 M
1
Emendo Biotherapeutics
Acquired
$61 M
4
MDClone
Active
Software
B2B
$41 M
4

Investment Rounds History

14

Funding Rounds

$4M -

$61M

Investment Round Size

Startup

Date Announced

Funding Round

Amount Raised

Investors

Funds Raised

Date Announced

Fund Number

Amount Raised

May 2016
2
$307M
March 2011
1
$203M

Similar Investors

RRE Ventures
TYPE
Venture Capital
Innovation Endeavors
TYPE
Venture Capital
TYPE
Angel
TYPE
Angel
Glilot Capital Partners
TYPE
Venture Capital
Sierra Ventures
TYPE
Venture Capital
MIN CHEQUE
$1 M
UpWest Labs
TYPE
Venture Capital
MIN CHEQUE
$0.25 M
Samsung NEXT
TYPE
Corporate Venture Capital
MIN CHEQUE
$1 M
Two Sigma Ventures
TYPE
Venture Capital
10D

10D

TYPE
Venture Capital
TYPE
Angel
Union Tech Ventures
TYPE
Corporate Venture Capital
Emery Capital
TYPE
Venture Capital
Fosun Group
TYPE
Corporate Venture Capital
Gefen Capital
TYPE
Venture Capital
Viola Ventures
TYPE
Venture Capital
MIN CHEQUE
$1 M
Debiopharm
TYPE
Company
Samsung Ventures
TYPE
Corporate Venture Capital
Israel Innovation Authority
TYPE
Government
Dell Technologies Capital
TYPE
Corporate Venture Capital

Investor Snapshot

Average Funding Round Size

$24 Million

No. of Investments

14

No. of Portfolio Companies

7

Largest Funding Round Size

$61 Million

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events